Science

Raising Biotech

by Surani Fernando

Claiming needs an RSS feed. Contact us.

Listen on Apple Podcasts

Recently ranked · United States

Last recorded placements from this show’s chart history. These are not current rankings.

Not on the United States charts we track today.

If you like Raising Biotech, try…

Simple & Easy Arabic Podcast

Similar topics: s4 and s3

Lead with Empathy

Similar topics: s4 and s3

Creative Career Change

Similar topics: s4 and s3

The Bros Of Gardening

Similar topics: s4 and s3

Wild Thing

Similar topics: s4 and s3

Latest episodes

S4, E8: Infinimmune – From a Scientific Hunch to an $838M Merck Partnership, with CEO and co-founder Wyatt McDonnell

September 3, 2026 · 30 min

In this episode, Surani explores the unconventional start-up story of Infinimmune, an antibody discovery company founded in 2022 by five former 10x Genomics scientists. Starting with a scientific hunch that advances in single-cell…
S4, E7: From the Archive – Revisiting Synchron and Brain-Computer Interfaces, 2 Years Later

July 1, 2026 · 38 min

In this July summer episode, we slow things down again and revisit a conversation from the Raising Biotech archive. Today's episode is a replay from November 2023, featuring Synchron, a company developing implantable brain-computer…
S4, E6: Investor Spotlight: From Cancer Physician to Biotech Investor, with Dr Jakob Dupont of Sofinnova Investments

June 3, 2026 · 30 min

In this special Investor Spotlight edition of Raising Biotech, Surani sits down with Dr. Jakob Dupont, Executive Partner at Sofinnova Investments, to explore one of the most unusual career trajectories in biotech. Before becoming a venture…
S4, E5: Compass Pathways and the Quest to Bring Psychedelics to Psychiatry, with CEO Kabir Nath and Prof David Nutt

May 6, 2026 · 37 min

In this episode, Surani explores one of biotech’s most controversial and ambitious frontiers: psychedelic medicine. At the center of the story is Compass Pathways, the London-based biotech attempting to bring synthetic psilocybin through…
S4, E4: The Weight of the Moment: How GLP-1s are Rewiring Biotech Investing, Expert Analysis

April 1, 2026 · 34 min

In this episode, Surani takes a deep dive with experts into biotechs hottest new hype cycle -- GLP-1s. Over the past couple years, biotech investing has felt like it’s entering a new gravitational field, with GLP-1s at the center. Once a…

Show 7 more episodesShow fewer episodes

S4, E3: Inside Opus Genetics’ Pivot – Skepticism, Proxy Fights and a Comeback, with CEO George Magrath

March 4, 2026 · 29 min

In this episode, Surani speaks with George Magrath, CEO of Opus Genetics, about the realities of leading a public biotech company through a major strategic pivot and intense market scrutiny. Opus Genetics emerged from a 2024 reverse merger…
S4, E2: From Medicine to IPOs - Dr Sheila Gujrathi on Raising Biotech Against the Odds

February 4, 2026 · 33 min

In this episode, we focus on the personal journey of Sheila Gujrathi, a physician turned biotech builder whose career spans medicine, big pharma, rapid IPOs, and billion dollar exits. We explore what it takes to raise biotech across…
S4, E1: From the Archive - Revisiting eGenesis and Xenotransplantation with Pig Organs, Two Years On

January 7, 2026 · 37 min

In this early-January episode, we slow things down, and reflect... Today’s episode is a replay from the Raising Biotech archive — a conversation originally recorded in November 2023 with eGenesis, a company working at the frontier of…
S3, E6: Veradermics puts hair loss back on the investor agenda with $150 million Series C - with CEO Dr Reid Waldman and InThought's Julie Hoggatt

December 3, 2025 · 37 min

In this episode, we dive into one of the most universal aesthetic concerns on the planet: pattern hair loss. Despite affecting more than 80 million people in the US and over a billion globally, innovations in treatment have barely moved in…
S3, E5: Special Analysis: What's going on with European Biotech? - Reporting from BioEurope in Vienna

November 5, 2025 · 19 min

In this special on-the-ground episode of Raising Biotech, Surani takes you inside BIO-Europe 2025 in Vienna — the dealmaking, the caffeine, and the cautious optimism shaping Europe’s biotech landscape right now. Over three packed days…
S3, E4: ReproNovo’s strategic trash-to-treasure bet on fertility and reproductive health - with CEO Jean Marie Duval

October 1, 2025 · 32 min

In this episode, we dive into ReproNovo’s “trash to treasure” biotech story. Founded in Switzerland in 2021, the company is reimagining reproductive medicine, one of the most underserved areas in biotech, by reviving overlooked and…
S3, E3: AltruBio’s Cinderella story from bankruptcy talks to a $225M Series B to tackle autoimmune diseases - with CEO Dr Judy Chou

September 3, 2025 · 32 min

In this episode, we look at AltruBio’s Cinderella story. While the company officially launched in 2020, its roots go back more than 20 years with a rich immunology pipeline stuck in “academic-style experiments.” On the brink of bankruptcy…

Full episode archive on Apple Podcasts →

About the show

A narrative podcast series hosted by journalist Surani Fernando that goes beyond the headlines to explore how biotech companies are really built — from bold ideas and impressive fundraises to the science that could reshape healthcare. Surani speaks with founders, CEOs, investors, and experts to uncover origin stories, company missions, and the challenges of bringing ambitious discoveries to market. Through thoughtful, independent reporting, Raising Biotech examines what it really takes to turn breakthroughs into lasting impact for patients and the industry. For guest or sponsor pitches, please get in touch with Surani Fernando on LinkedIn or email raisingbiotech@gmail.com.